{"transactions":[{"id":965090,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71318,"kind":"person","name":"Hendricks Diane","position":1,"cik":"0001727478","reported_name":"Hendricks Diane","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-12-17T15:42:31.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":false,"shares":43499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported disposition relates to pro rata distribution by Gem Pharmaceuticals, LLC (\"Gem\") to its members in which the reporting person has no pecuniary interest.  Pharma Investments LLC (\"Pharma\") owns a controlling share of Gem and the reporting person, a manager of Gem, owns a controlling share of Pharma, so Pharma and its controlling shareholders have indirect control over the securities described herein. The managers of Gem and the controlling shareholders of Pharma each disclaim ownership of the shares of common stock owned by Gem, except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reported disposition relates to pro rata distribution by Gem Pharmaceuticals, LLC (\"Gem\") to its members in which the reporting person has no pecuniary interest.  Pharma Investments LLC (\"Pharma\") owns a controlling share of Gem and the reporting person, a manager of Gem, owns a controlling share of Pharma, so Pharma and its controlling shareholders have indirect control over the securities described herein. The managers of Gem and the controlling shareholders of Pharma each disclaim ownership of the shares of common stock owned by Gem, except to the extent of their pecuniary interest therein."}],"balance_after":567580,"source":{"system":"sec-edgar","filing":"0001437749-25-038139","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727478/000143774925038139/rdgdoc.xml","form_type":"4"}},{"id":3334001,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71318,"kind":"person","name":"Hendricks Diane","position":1,"cik":"0001727478","reported_name":"Hendricks Diane","relationship":{"director":false,"officer":false,"ten_percent_owner":true}}],"security":"Common stock","published_at":"2019-12-20T19:10:14.000Z","date":"2019-12-18","kind":"purchase","acquired":true,"shares":468750,"price":8,"value":3750000.0,"ownership":{"direct":false,"nature":"See Footnote 1"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This is based upon the 468,750 shares of Monopar Common Stock that DMH Business LLC directly owns. As a manager of DMH Business LLC, Ms. Hendricks may be deemed to share voting and dispositive power over these 468,750 shares. Ms. Hendricks disclaims beneficial ownership of the 468,750 shares held by DMH Business LLC, except to the extent of her pecuniary interest therein."}],"balance_after":468750,"source":{"system":"sec-edgar","filing":"0001654954-19-014155","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727478/000165495419014155/section16.xml","form_type":"4"}}]}